Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Celera Genomics to Present at William Blair Growth Investors Conference June 25.


Business Editors/Health/Medical Writers

BIOWIRE2K

ROCKVILLE, Md.--(BUSINESS WIRE)--June 18, 2003

Celera Genomics (NYSE NYSE

See: New York Stock Exchange
:CRA See Community Reinvestment Act. ), an Applera Corporation business, today announced that Kathy Ordonez, President of Celera Genomics and Celera Diagnostics, will present at the William Blair
People:
  • William M. Blair, investment banker from Chicago
  • William J. L. Blair, Tony Blair's brother
  • William W. Blair (1828–1896), leader in the Reorganized Church of Jesus Christ of Latter Day Saints (RLDS Church)
 23rd Annual Growth Stock Conference on Wednesday, June 25, 2003, at 8:30 a.m. CDT CDT
abbr.
Central Daylight Time


CDT Central Daylight Time

CDT n abbr (US) (= Central Daylight Time) → hora de verano del centro;
(BRIT
 at the Four Seasons Hotel in Chicago, Illinois.

The presentation will be webcast and can be accessed by visiting the Celera Genomics Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 web site at www.celera.com. The webcast replay will be available through September 25, 2003.

About Celera Genomics and Applera Corporation

Applera Corporation comprises two operating groups. The Celera Genomics Group, located in Rockville, MD, and South San Francisco South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , CA, is engaged principally in integrating advanced technologies to discover and develop new therapeutics. Celera intends to leverage its proteomic, bioinformatic, and genomic capabilities to identify and validate drug targets and to discover and develop new therapeutics. Its Celera Discovery System(TM) online platform, marketed exclusively through the Applied Biosystems Knowledge Business, is an integrated source of information based on the human genome and other biological and medical sources. The Applied Biosystems Group (NYSE:ABI Abi (ā`bī) [short for Abijah], in the Bible, King Hezekiah's mother.


(Application Binary Interface) A specification for a specific hardware platform combined with the operating system.
) develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.6 billion during fiscal 2002. Celera Diagnostics, a 50/50 joint venture between Applied Biosystems and Celera Genomics, is focused on discovery, development, and commercialization of novel diagnostic products. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at www.applera.com, or by telephoning 800.762.6923. Information about Celera Genomics is available at www.celera.com.

Copyright (C) 2003. Applera Corporation. All Rights Reserved. Applied Biosystems, Celera, Celera Diagnostics and Celera Genomics are registered trademarks of Applera Corporation or its subsidiaries in the U.S. and certain other countries.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 18, 2003
Words:328
Previous Article:The Classica Group Enters into Agreement with Wall Street Private Equity Hedge Fund.
Next Article:America's Car-Mart, Inc. Schedules Release of Fourth Quarter Results, Fiscal 2003 Results and Conference Call.
Topics:



Related Articles
Celera Genomics Group Reports Fourth Quarter and Fiscal 2001 Year End Results.
Celera Reports Second Quarter Revenues of $35.0 Million.
Applied Biosystems Group and Celera Genomics Group Third Quarter FY 2002 Financial Results and Conference Call Scheduled for Release April 25, 2002.
Applied Biosystems to Present at Goldman Sachs Healthcare Conference on June 11.
Applied Biosystems Reports Fourth Quarter and Fiscal 2003 Results.
Celera Genomics and Celera Diagnostics to Webcast Presentation At UBS Global Life Sciences Conference.
Celera Genomics & Celera Diagnostics to Webcast Presentation at R.W. Baird Growth Stock Conference.
Applied Biosystems to Webcast Presentation at Pacific Growth Equities Life Sciences Growth Conference.
Applied Biosystems Reports Fourth Quarter and Fiscal 2004 Results.
Celera Genomics Reports Third Quarter Fiscal 2005 Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles